Literature DB >> 11368259

Q fever during pregnancy: an emerging cause of prematurity and abortion.

F Jover-Díaz1, J Robert-Gates, L Andreu-Gimenez, J Merino-Sanchez.   

Abstract

BACKGROUND: Although the pathogenic role of Coxiella burnetii infection during pregnancy is controversial, some cases of stillbirth and abortion occurring after an acute or chronic infection have been mentioned in the literature. Recently, Q fever has been advocated as a significant cause of morbidity and mortality in pregnancy CASE: We describe an 18-year-old primipara woman admitted to our hospital for high fever and pancytopenia during an acute C. burnetii infection. She was successfully treated with clarithromycin, overcoming fever and pancytopenia. Finally, she gave birth to a healthy infant, and 1 year later both remained well.
CONCLUSION: Q fever is a potentially serious disease in pregnancy owing to the possibility of placenta infection and fetal transmission affecting its outcome. Q fever infection should be suspected in unexplained febrile episodes or abortion during pregnancy, when epidemiologic and clinical data are present. We believe that C. burnetii serology should be tested in cases of fever of known origin or unexplained abortions, as the TORCH infections are.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11368259      PMCID: PMC1784628          DOI: 10.1155/S1064744901000084

Source DB:  PubMed          Journal:  Infect Dis Obstet Gynecol        ISSN: 1064-7449


  8 in total

1.  Comparison of different antibiotic regimens for therapy of 32 cases of Q fever endocarditis.

Authors:  P Y Levy; M Drancourt; J Etienne; J C Auvergnat; J Beytout; J M Sainty; F Goldstein; D Raoult
Journal:  Antimicrob Agents Chemother       Date:  1991-03       Impact factor: 5.191

2.  Q fever in pregnancy: case report after a 2-year follow-up.

Authors:  A Téllez; J Sanz Moreno; D Valkova; C Domingo; P Anda; F de Ory; F Albarrán; D Raoult
Journal:  J Infect       Date:  1998-07       Impact factor: 6.072

Review 3.  Q fever during pregnancy: a public health problem in southern France.

Authors:  A Stein; D Raoult
Journal:  Clin Infect Dis       Date:  1998-09       Impact factor: 9.079

4.  Q fever in pregnancy.

Authors:  H Ludlam; T G Wreghitt; S Thornton; B J Thomson; N J Bishop; S Coomber; J Cunniffe
Journal:  J Infect       Date:  1997-01       Impact factor: 6.072

5.  Q fever during pregnancy--a risk for women, fetuses, and obstetricians.

Authors:  D Racult; A Stein
Journal:  N Engl J Med       Date:  1994-02-03       Impact factor: 91.245

6.  Histiocytic hemophagocytosis in Q fever.

Authors:  Z Estrov; R Bruck; M Shtalrid; A Berrebi; P Resnitzky
Journal:  Arch Pathol Lab Med       Date:  1984-01       Impact factor: 5.534

7.  Hemophagocytosis: a complication of acute Q fever in a child.

Authors:  M Hufnagel; C Niemeyer; L B Zimmerhackl; T Tüchelmann; S Sauter; M Brandis
Journal:  Clin Infect Dis       Date:  1995-10       Impact factor: 9.079

8.  In vitro susceptibility of Coxiella burnetii to trovafloxacin in comparison with susceptibilities to pefloxacin, ciprofloxacin, ofloxacin, doxycycline, and clarithromycin.

Authors:  A Gikas; I Spyridaki; A Psaroulaki; D Kofterithis; Y Tselentis
Journal:  Antimicrob Agents Chemother       Date:  1998-10       Impact factor: 5.191

  8 in total
  9 in total

1.  Q fever and pregnancy: disease, prevention, and strain specificity.

Authors:  E Angelakis; M Million; F D'Amato; L Rouli; H Richet; A Stein; J-M Rolain; D Raoult
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-09-28       Impact factor: 3.267

Review 2.  From Q Fever to Coxiella burnetii Infection: a Paradigm Change.

Authors:  Carole Eldin; Cléa Mélenotte; Oleg Mediannikov; Eric Ghigo; Matthieu Million; Sophie Edouard; Jean-Louis Mege; Max Maurin; Didier Raoult
Journal:  Clin Microbiol Rev       Date:  2017-01       Impact factor: 26.132

Review 3.  Antimicrobial therapies for Q fever.

Authors:  Gilbert J Kersh
Journal:  Expert Rev Anti Infect Ther       Date:  2013-09-27       Impact factor: 5.091

4.  Attenuated Coxiella burnetii phase II causes a febrile response in gamma interferon knockout and Toll-like receptor 2 knockout mice and protects against reinfection.

Authors:  Javier Ochoa-Repáraz; Jami Sentissi; Theresa Trunkle; Carol Riccardi; David W Pascual
Journal:  Infect Immun       Date:  2007-09-24       Impact factor: 3.441

5.  Antibodies against Coxiella burnetii and pregnancy outcome during the 2007-2008 Q fever outbreaks in The Netherlands.

Authors:  Wim van der Hoek; Jamie C E Meekelenkamp; Alexander C A P Leenders; Nancy Wijers; Daan W Notermans; Chantal W P M Hukkelhoven
Journal:  BMC Infect Dis       Date:  2011-02-11       Impact factor: 3.090

6.  Serosurvey and observational study of US Army Veterinary Corps officers for Q fever antibodies from 1989 to 2008.

Authors:  K G Vest; L L Clark
Journal:  Zoonoses Public Health       Date:  2013-07-17       Impact factor: 2.702

7.  Vaccination against Q fever for biodefense and public health indications.

Authors:  Sara Ruiz; Daniel N Wolfe
Journal:  Front Microbiol       Date:  2014-12-16       Impact factor: 5.640

8.  Seropositivities against brucellosis, coxiellosis, and toxoplasmosis and associated factors in pregnant women with adverse pregnancy outcomes: A cross-sectional study.

Authors:  Kan Kledmanee; Tippawan Liabsuetrakul; Somporn Sretrirutchai
Journal:  PLoS One       Date:  2019-05-09       Impact factor: 3.240

9.  Neurotransmitter System-Targeting Drugs Antagonize Growth of the Q Fever Agent, Coxiella burnetii, in Human Cells.

Authors:  Marissa S Fullerton; Punsiri M Colonne; Amanda L Dragan; Katelynn R Brann; Richard C Kurten; Daniel E Voth
Journal:  mSphere       Date:  2021-07-07       Impact factor: 4.389

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.